The objective of this study was to determine whether the intrathymic injection of islets can prevent the development of diabetes in BB/Wor rats. Evidence suggests that a failure to induce islet thymic tolerance may be an etiological factor in the development of the disease. It was theorized that the introduction of islets into the thymus might directly induce islet tolerance and thus prevent disease. Islets from diabetes-resistant BB/Wor rats were injected into the thymuses of 23 young diabetes-prone BB/Wor rats; 25 sham-operated animals served as controls. Results showed that 22 of the 25 control rats became diabetic while only 8 of the 23 experimental rats became diabetic (P < 0.0002). The specific lysis of islet cells by spleen cells from nondiabetic experimental and control rats was comparable and less than the lysis induced by spleen cells from diabetic rats. These data demonstrate that the intrathymic injection of islets into diabetes-prone BB/Wor rats is an effective method for preventing the development of autoimmune type I diabetes. (J. Clin. Invest.
Introduction
The BB/Wor rat spontaneously develops a diabetic syndrome similar to that of type I diabetic humans (1) (2) (3) . These animals are ketosis prone and require insulin for survival. Though they are lymphopenic, cell-mediated immune processes have been implicated in the destruction of their islet cells, specifically those involving natural killer cells and T lymphocytes (4) (5) (6) (7) . In support of a role for T lymphocytes, thymectomy has been shown to prevent diabetes in BB/Wor rats (8) .
Prevention ofBB/Wor rat diabetes by thymectomy focused attention on the role of the thymus in the etiology of the disease. Data suggested that the thymus of diabetes-prone (DP)' rats was defective (9, 10) . Georgiou et al. (1 1) demonstrated that DP thymuses harbored defective macrophage-like antigen presenting cells (APCs) which were responsible for the activation of effector lymphocytes capable of destroying islet cells. Normally, thymic APCs are thought to play an important role in the generation ofselftolerance (12) . Since it appears that the development of diabetes in the BB/Wor rat may be due to an abnormal bone marrow-derived thymic APC, it was assumed that some defect in self-tolerance induction may be involved in disease development.
The objective of this study was to determine whether bolstering immunological tolerance to islet antigens can prevent the development of autoimmune diabetes in the rat. Injection ofislets intrathymically might be one mechanism by which the activity ofthymic APCs, vis-a-vis their role in establishing islet tolerance, could be enhanced. Ihm et al. (13) suggested that islets from rats of the age at which self tolerance is normally induced, i.e., neonates, lacked certain antigenic determinants, which could also explain the lack of islet tolerance in adult BB/Wor rats. Intrathymic injection of adult islets containing these antigens could help to reestablish islet tolerance. An important precedent for this study comes from the work ofPosselt et al. (14) , who successfully induced donor-specific unresponsiveness by transplanting islets intrathymically into two-month old, streptozotocin-induced diabetic allogeneic recipients.
Methods
Animals. BB/Wor rats were obtained from the University ofMassachusetts breeding facility. 48 DP rats were used in this study. In addition, diabetes-resistant (DR) rats, used as a source of islet cells, and a small number of acutely diabetic BB/Wor rats (within five days of onset) were also used. Diabetes develops in DP animals at a mean (±SE) age of 78.4±0.5 d; the frequency of disease is between 80 and 90% (15) . All DP rats used in this study were monitored for the presence of urine glucose starting at 50 days of age, using Testape (Eli Lilly & Co., Indianapolis, IN).
Intrathymic injection of islets. Islets were isolated from 3-mo old DR rats as previously described (5) . Before injection, the islets were irradiated with 1,800 rads (see Discussion). The cells were then washed twice and resuspended in serum-free RPMI medium in a siliconized tube. The yield from one to two rats (300-600 islets) was injected into each recipient thymus in a volume of 0.1 ml. Under ketamine/ropum anesthesia (0.1 ml/100 g body wt), the lower ventral neck and suprasternal regions of recipient rats were exposed. The superficial muscles as well as the upper few millimeters of the sternum were cut through, exposing the thymus. The islets were injected into the thymus using a 1-cc syringe with a 27G needle. The wound was sealed using surgical staples. 23 (17) .
Results
Effects ofintrathymic islet injection on diabetes incidence
The intrathymic injection of islets into DP rats significantly reduced (P < 0.0002) their incidence of diabetes. These results are shown in Table I 
5lCr-release assay
Spleen cells from a number of nondiabetic experimental (n = 10) and control (n = 3) DP rats were analyzed for their ability to lyse islet and YAC-1 cell targets. Results are shown in Table  II . There were no significant differences between the level of killing of islet or YAC-1 cells between experimental and control rats. Lysis ofislet cells by spleen cells from both experimental nondiabetic (mean±SE was 15.9±1.6) and control nondiabetic (16.4±1.1) animals was significantly lower (P < 0.001) than lysis by spleen cells from diabetic rats (26.4±1.4; n = 4). YAC-1 lysis by spleen cells from experimental nondiabetic (60±1.6) and control (54.5±2.5) animals were insignificantly different from lysis by spleen cells from diabetic rats (59.4±1.5; n = 4). FACS® The mean±SE concentrations of OXl9+ and OX8+/OX19-cells were 1 1.0±0.5% and 18.0±1.0%, respectively, in the experimental group (n = 10) and 9.4±0.7% and 14.5±3.0%, respectively, in the control group (n = 3) (not significant). The mean±SE concentrations ofOX8+/OX 19+ cells were 1.2±0.1 in the experimental group and 0.9±0.1% in the control group (P < 0.02 compared to experimental group).
Discussion
The objective of this study was to determine whether the intrathymic injection of islets into DP rats can prevent the development of disease in the BB/Wor rat. Our results suggest that Morphological examination of the thymuses of protected animals revealed relatively few islets, considering the number injected, in spite ofthe fact that three thymic levels were examined. Intact islets were observed only within thymic connective tissue septa. Islet cells that were localized within the lymphocyte parenchyma ofthe thymus were present as small, isolated clusters of few cells and not as intact islets. Most of these cells seemed to be present in or near the thymic medulla. What might be speculated from these observations is that islets do not survive well in the thymic cortex, perhaps because thymic macrophages and lymphocytes have eliminated them in the process of presenting them to maturing T cells. A time course study of the disposition ofintrathymic islets should help to clarify these findings. It is not immediately clear why all ofthe experimental animals were not protected from the development of diabetes, since they all appeared to have the same pattern of islet distribution within their thymuses. A quantitative time course analysis of the fate of intrathymic islets should also help to answer this question.
Recall that the islets were first irradiated before their intrathymic injection. This was done in an attempt to interfere with their ability to release insulin in response to glucose. Gotfredsen et al. (18) and Like (19) suggested that insulin injections could prevent the development of BB rat diabetes by diminishing the activity and size, and consequently the immunogenicity, of their islets. Though the possibility seemed remote that the levels of insulin released from intrathymic islets could reach high enough levels to reduce the activity ofthe pancreatic islets, we thought we would try to eliminate this possibility altogether by the simple method of irradiation. Our data (not shown) suggested that irradiation had no effect on the inhibition of islet insulin secretion. It should be emphasized, however, that the possibility that insulin, released from intrathymic islets, could play a role in diabetes prevention is considered very remote. Data from Hegre et al. showed that transplantation ofislets into DP rats before 60 days ofage did not appear to affect their incidence ofdiabetes (20) . In addition, subjectively, the size of the pancreatic islets of protected animals appeared similar to the size ofthe islets in the pancreata ofcontrol, nondiabetic rats; thus a "shutting down" of the pancreatic islets did not seem to be occurring. (24) showed no changes in lymphocyte subsets after total lymphoid irradiation in diabetes-protected animals. Changes in the activity of lymphocytes within a given subset may have accounted for these, and our present, findings.
Evidence suggests that a failure to induce islet tolerance may be an etiological factor in the development of diabetes.
This evidence includes the data of Georgiou et al. (11) , who showed that thymic APCs in DP rats may be defective in their ability to establish islet tolerance. In all likelihood, this lack of tolerance induction manifests itself by the absence ofcells capable of suppressing islet effectors. Furthermore, the data of Ihm et al. (13) suggested that islets from rats of the age at which self tolerance is normally induced, i.e., neonates, lacked certain antigenic determinants, which could explain the lack of islet tolerance in adult DP rats. In support of Ihm's data, Buschard et al. (25) reported that diabetes in BB rats can be prevented by the neonatal stimulation of beta cells. This procedure was thought to induce or enhance antigen expression on the beta cells, which facilitated the immune system's ability to develop beta cell tolerance (26) .
As mentioned earlier, Posselt et al. (14) were successful in inducing donor-specific unresponsiveness by transplanting islets intrathymically into two-month old streptozotocin-induced diabetic allogeneic recipients. Not only were the intrathymic islets not rejected, but once tolerance was achieved, islets transplanted to extrathymic sites were also protected. Our study is significant since it shows that not only rejection but specific autoimmune attack can be prevented by intrathymic islet injection. Recall that in a diabetic recipient of an identical twin's pancreatic graft, a specific autoimmune attack was responsible for the destruction of the beta cells in that graft soon after transplantation (27) . While it is tempting to attribute the findings presented here to the induction of specific islet tolerance, such a conclusion awaits further experimentation.
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